152 related articles for article (PubMed ID: 2575061)
41. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis.
Bate CM; Griffin SM; Keeling PW; Axon AT; Dronfield MW; Chapman RW; O'Donoghue D; Calam J; Crowe J; Mountfords RA; Watts DA; Taylor MD; Richardson PD
Aliment Pharmacol Ther; 1996 Aug; 10(4):547-55. PubMed ID: 8853758
[TBL] [Abstract][Full Text] [Related]
42. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
[TBL] [Abstract][Full Text] [Related]
43. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
Alliët P; Raes M; Bruneel E; Gillis P
J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
[TBL] [Abstract][Full Text] [Related]
44. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
[TBL] [Abstract][Full Text] [Related]
45. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
[TBL] [Abstract][Full Text] [Related]
46. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
Piai G; Sabbatini F; Mazzacca G
Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
[No Abstract] [Full Text] [Related]
47. Treatment of acid-related disorders with gastric acid inhibitors: the state of the art.
Blum AL
Digestion; 1990; 47 Suppl 1():3-10; discussion 49-52. PubMed ID: 1982662
[TBL] [Abstract][Full Text] [Related]
48. [Therapeutic strategy in the treatment of gastroesophageal reflux].
Zeitoun P; Carteret E; Bouché O
Acta Gastroenterol Belg; 1990; 53(5-6):568-72. PubMed ID: 1983374
[TBL] [Abstract][Full Text] [Related]
49. How do you spell relief in reflux esophagitis? PPI!
Fennerty MB
Gastroenterology; 1996 Sep; 111(3):826-7. PubMed ID: 8780593
[No Abstract] [Full Text] [Related]
50. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
[TBL] [Abstract][Full Text] [Related]
51. Australian clinical trials of omeprazole in the management of reflux oesophagitis.
Dent J
Digestion; 1990; 47 Suppl 1():69-71. PubMed ID: 2093019
[TBL] [Abstract][Full Text] [Related]
52. The medical therapy of reflux oesophagitis.
Tytgat GN; Nio CY
Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
[TBL] [Abstract][Full Text] [Related]
53. [Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].
Kim JW; Kim HS; Lee DK; Suk KT; Kim JM; Baik SK; Kwon SO; Cho MY
Korean J Gastroenterol; 2004 Mar; 43(3):153-9. PubMed ID: 15034285
[TBL] [Abstract][Full Text] [Related]
54. [Conservative therapy of reflux esophagitis].
Koop H
Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350
[No Abstract] [Full Text] [Related]
55. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
Chiba N
Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
[TBL] [Abstract][Full Text] [Related]
56. A comparison of five maintenance therapies for reflux esophagitis.
Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
[TBL] [Abstract][Full Text] [Related]
57. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Lundell L
Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
[TBL] [Abstract][Full Text] [Related]
58. The success of histamine-2 receptor antagonists.
Morris AI
Scand J Gastroenterol Suppl; 1992; 194():71-5. PubMed ID: 1363678
[TBL] [Abstract][Full Text] [Related]
59. [Long-term results of conservative management of reflux esophagitis].
Viani F; Dorta G
Ther Umsch; 2001 Mar; 58(3):146-50. PubMed ID: 11305152
[TBL] [Abstract][Full Text] [Related]
60. Safety experience from long-term treatment with omeprazole.
Joelson S; Joelson IB; Lundborg P; Walan A; Wallander MA
Digestion; 1992; 51 Suppl 1():93-101. PubMed ID: 1397750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
